These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 18535618)
1. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy. Gao Y; Ng SS; Chau DH; Yao H; Yang C; Man K; Huang PT; Huang C; Huang JJ; Kung HF; Lin MC Cancer Gene Ther; 2008 Nov; 15(11):723-32. PubMed ID: 18535618 [TBL] [Abstract][Full Text] [Related]
2. A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide. Ng SS; Gao Y; Chau DH; Li GH; Lai LH; Huang PT; Huang CF; Huang JJ; Chen YC; Kung HF; Lin MC Cancer Gene Ther; 2007 Jun; 14(6):561-72. PubMed ID: 17384579 [TBL] [Abstract][Full Text] [Related]
3. Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail. Liu X; Li XP; Peng Y; Ng SS; Yao H; Wang ZF; Wang XM; Kung HF; Lin MC Chin J Cancer; 2012 Dec; 31(12):588-97. PubMed ID: 23149313 [TBL] [Abstract][Full Text] [Related]
4. [Enhancement of target gene expression by recombinant adeno-associated virus combined with recombinant adenovirus in vivo]. Liu X; Li G; Li Q; Tian WD; Zhang W; Chen HH; Li XP Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):44-8. PubMed ID: 21269954 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice. Huo L; Yao H; Wang X; Wong GW; Kung HF; Lin MC PLoS One; 2010 Sep; 5(9):e12705. PubMed ID: 20856939 [TBL] [Abstract][Full Text] [Related]
6. [Immune potency of recombinant adeno-associated virus combined with recombinant adenovirus vaccine containing HIV-1 gp120]. Feng X; Yu SQ; Chen GM; Wu XB; Zuo JM; Dong WP; Zhou L; Zeng Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):312-5. PubMed ID: 15650777 [TBL] [Abstract][Full Text] [Related]
7. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector. Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450 [TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy. Małecki M; Swoboda P; Pachecka J Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976 [TBL] [Abstract][Full Text] [Related]
9. [Enhanced transduction efficiency of adeno-associated virus on cancer cells with the help of low dose adenovirus]. Li HM; Wang F; Wei F; Dong XY; Wang HP; Qiu W; Zhang JF; Chen XF; Wu XB; Huang Q Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1987-90. PubMed ID: 17923042 [TBL] [Abstract][Full Text] [Related]
10. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597 [TBL] [Abstract][Full Text] [Related]
11. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector. Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229 [TBL] [Abstract][Full Text] [Related]
12. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations. Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197 [TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin. Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731 [TBL] [Abstract][Full Text] [Related]
14. AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma. Harding TC; Lalani AS; Roberts BN; Yendluri S; Luan B; Koprivnikar KE; Gonzalez-Edick M; Huan-Tu G; Musterer R; VanRoey MJ; Ozawa T; LeCouter RA; Deen D; Dickinson PJ; Jooss K Mol Ther; 2006 May; 13(5):956-66. PubMed ID: 16580881 [TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model. Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019 [TBL] [Abstract][Full Text] [Related]
16. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells. Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085 [TBL] [Abstract][Full Text] [Related]
17. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Liu XL; Clark KR; Johnson PR Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114 [TBL] [Abstract][Full Text] [Related]
18. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach. Zhang X; Li CY Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083 [TBL] [Abstract][Full Text] [Related]
19. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment. Hoffmann D; Wildner O Cancer Gene Ther; 2007 Jul; 14(7):627-39. PubMed ID: 17479104 [TBL] [Abstract][Full Text] [Related]
20. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy. Hsu PY; Yang YW J Gene Med; 2005 Oct; 7(10):1311-21. PubMed ID: 15906397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]